The scope of JIS broadens Penetrating the Ortho
Post# of 7791
(Total Views: 314)
Posted On: 08/29/2022 2:45:08 PM
The scope of JIS broadens
Penetrating the Orthopedic Surgery Market with millions of surgeries a year is a major move forward for BIEL.
JIS Orthopedics was acquired in 1/2022 by the OrthoAlliance
The OrthoAlliance has 25 facilities and 70 doctors.
Dr Keith Berend, who has been with JIS for 9 years, is now the Chief Medical Development Officer at OrthoAlliance.
The JIS use of RecoveryRx will now be shared with 62 other Orthopedic Surgeons.
https://joinorthoalliance.com/#s6
(recommend watching the "Intro Video" on this page)
https://www.jointimplantsurgeons.com/physicia...ith-berend
Penetrating the Orthopedic Surgery Market with millions of surgeries a year is a major move forward for BIEL.
JIS Orthopedics was acquired in 1/2022 by the OrthoAlliance
The OrthoAlliance has 25 facilities and 70 doctors.
Dr Keith Berend, who has been with JIS for 9 years, is now the Chief Medical Development Officer at OrthoAlliance.
The JIS use of RecoveryRx will now be shared with 62 other Orthopedic Surgeons.
https://joinorthoalliance.com/#s6
(recommend watching the "Intro Video" on this page)
https://www.jointimplantsurgeons.com/physicia...ith-berend
(4)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼